Where does Bionano Genomics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bionano Genomics, Inc. ranks #10,559 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bionano Genomics, Inc. hold?

Bionano Genomics, Inc. holds 29 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Bionano Genomics, Inc.'s Innovation Score?

Bionano Genomics, Inc. has an Innovation Score of 42.7 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Bionano Genomics, Inc.'s patent grant rate increasing or decreasing?

Bionano Genomics, Inc.'s recent grant velocity is +8% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bionano Genomics, Inc.'s patents?

Bionano Genomics, Inc.'s patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bionano Genomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bionano Genomics, Inc.

Q: What technology areas does Bionano Genomics, Inc. focus on?

Bionano Genomics, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 22 patents, ranking #214 of 2,502 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 29 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bionano ranks #10,559 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 9 technology areas.

#10,559
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.7/100): 19.6
avg claims per patent: +8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10559 · US Corporation #10,559 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,559/49,997
PHOTO-FINISH Barclays Execution…
CPC-NARROW C12Q · 9 areas
INNOV-PAR 42.7/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +8% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Barclays Execution Services Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bionano’s 42.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (27%) Velocity 8.6 pts (20%) Breadth 10.6 pts (25%) Claim depth 11.7 pts (27%)

Qualcomm Incorporated · highest

85
8×8 · near

43
Bionano Genomics · this assignee

43
Noven Pharmaceuticals · near

43
Qwtip · near

43
Wireless Advanced… · near

43
3D Lighting… · lowest

7

What this shows Bionano's Innovation Score is 42.7/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bionano?

Each dot is one of Bionano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bionano’s own 19.6 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bionano vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bionano's grants concentrate

Bionano Genomics, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 75.9% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2016. By volume, Bionano sits between Beijing Kohler Ltd. and Blue Force Gear, Inc..

Bionano's three-year grant acceleration

Bionano Genomics, Inc. shows 9 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Beijing Kohler

29
Belden Canada

29
Belden Canada ULC

29
BHA Altair

29
Bonoli S R L

29
Barclays Executio…

29
Bear Robotics

29
Blue Force Gear

29
Bionano Genomics ◀

29

What this shows Bionano holds 29 patents at rank #10,558, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bionano

By rank, the assignees closest to #10,558 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Bionano's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bionano, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Bionano ranks #214 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Qwtip LLC 43 Noven Pharmaceuticals, Inc. 43 Wireless Advanced Vehicle Electrification, LLC 43 8×8, Inc. 43

Bionano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bionano Genomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.9%
2016	1	3.4%
2017	6	20.7%
2018	2	6.9%
2019	2	6.9%
2020	4	13.8%
2021	1	3.4%
2022	4	13.8%
2023	1	3.4%
2024	4	13.8%
2025partial year	2	6.9%

Which technologies does Bionano Genomics, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 22

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 10

Y10T - Technical Subjects Covered BY Former US Classification 8

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 5

B81B - Microstructural Devices OR Systems, e.g. Micromechanical Devices 4

B81C - Processes OR Apparatus Specially Adapted FOR THE Manufacture OR Treatment OF Microstructural Devices OR Systems 4

B08B - Cleaning IN GENERAL; Prevention OF Fouling IN General 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bionano Genomics, Inc.'s patent record in context - here's where to go next.

Bionano Genomics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 75.9% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #10,559 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bionano Genomics, Inc. against Beijing Kohler Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.